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Chronic Obstructive Pulmonary Disease (COPD) is a common 
preventable and treatable disease, is characterized by persistent airflow 
limitation that is usually progressive and associated with an enhanced chronic 
inflammatory response in the airways and the lung to noxious particles or 
gases. Exacerbations and comorbidities contribute to the overall severity in 
individual patients. [1] 
According to WHO 2012, Chronic Obstructive Pulmonary Disease is 
now the third leading cause of death next to ischemic heart diseases and 
stroke.[2] Several studies have shown that the prevalence of COPD is 
increasing faster among women. In developed and industrialised nations active 
smoking seems to play a major role and in developing countries exposure to 
biomass seems to be a major factor. 
Non smokers with COPD are more often women proving genetic 
predisposition, environmental influences and greater vulnerability of women’s 
lungs. Their lungs are more susceptible to damage from air pollution and 
smoking. Sexual dimorphism of the human immune response may be 
responsible for the gender differences in the disease.  
 Little is known about the biomass related phenotype because 
pathophysiology related to biomass smoke is less understood. Rivera et al in 
his autopsy found that lung of individuals exposed to biomass displayed more 
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bronchiolitis and emphysema.[3] Do living patients with COPD due to biomass 
will have similar findings is not known. 
Women are more likely to be diagnosed with asthma instead of COPD. 
So, greater chances of underdiagnosis and receiving inadequate treatment for 
their condition. Women also report poor quality of life when compared with 
men, hence the urgent need for identification of COPD in women, the probable 
risk factors associated, most common presenting symptoms and their impact on 
life. Women report greater anxiety , more depressive symptoms, more dyspnea 
and chronic cough. They also have a poor quality of life, poor nutritional status, 
higher frequency of exacerbation. Osteoporosis, anxiety and depression were 
common in women with COPD. Women seem to be more sensitive to the 
adverse effects of beta 2 agonists.  
Hence, we plan to study the epidemiology and presentation of COPD , 
its impact on physiologic and pathologic impairments ,the probable risk factors 




REVIEW OF LITERATURE 
“IS  FEMALE  GENDER  DIFFERENT ?” 
Underdiagnosis of COPD in women 
Chapman k et al found that when hypothetical case of both man and a 
woman presented to the primary care physician with cough, dyspnea and 
smoking history , COPD was the most likely diagnosis for the male case 
scenario than the female. But with the use of spirometry the likelihood of 
diagnosis narrowed between men and women [4]. The  primary care physicians 
are less likely to use spirometry.  Women may not be referred to a higher centre 
for further diagnosis and less likely to receive spirometry.  Ancochea et 
al. reveals the significant underdiagnosis that exists in Spain in women with 
COPD, and leads us to reflect on how to improve its diagnosis in the female 
population. [5]In most of these studies where there was underdiagnosis like the 
PLATINO study,  the women tend to be younger and non smokers .[6] 
Physiology of women COPD 
We see increased incidence of  asthma in boys when less than 15 years, 
but steadily increasing in women thereafter till perimenopausal period and 
there is also premenstrual aggravation of symptoms in airway diseases. All 




Histologically , female patients had bronchioles with thick airway walls 
with increased epithelial and adventitial component and also a smaller lumen. 
We also see increased prevalence of chronic asthmatic bronchitis in females 
due to that.  
There is an increased responsiveness of the innate and adaptive 
inflammatory leukocytes of the female immune system leading to progressive 
infiltration of the lungs progressing to chronic inflammation. Emphysema may 
be an autoimmune disease and certain females with end stage emphysema have 
anti endothelial cell antibodies. In general autoimmune diseases are more 
prevalent in women which contributes to the above factor.[8] 
Increased susceptibility to smoking and indoor air pollution 
Women are at geater risk of lung function impairment than men for the 
same level of tobacco exposure. Female current smokers have a faster annual 
decline in lung function compared to their male counterparts.[9] The reasons 
may be  
1 .  First degree female relatives of probands who were current or ex 
smokers had greater reduced FEV1 than the male first degree relatives 
all indicating a genetic predisposition that is gender specific 
2 .   Women tend to underreport tobacco consumption [10] 
3 .   A dose dependant effect as the smaller airway of females have 
proportionately greater exposure.  
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4 .  Hormonal effects on lung and airway size leading to increased 
sensitivity of airway receptors and increased heavy metal absorption due 
to menstruation induced anemia. [7] 
5 .    The women do the cooking and spend most of their day  near the wood 
stove because most of the households do not even have separate kitchen. 
The smaller lung volume and smaller calibre of airways are more 
susceptible to the damaging effects of biomass exposure.  
6 .   Girls have an earlier and accelerated  lung growth than boys , but as 
adults have a smaller lung volume than men .The child tends to spend 
time with the mother , eating and sleeping near the wood stove. Thus 
their lungs are exposed to the harmful effects of biomass particulate 
matter even during the early stages of its development  and later in life 
leading to airway diseases . 
7 .   Hormone replacement therapy (HRT) users 25% less likely to have 
decline in lung function than their counterparts not using HRT. [11] 
Clinical presentation and symptoms of COPD in females 
Women  were significantly younger, reported more cough and  less 
phlegm probably be a cultural or societal artefact as they tend to 
swallow and less likely admit of having it. Dyspnea in women occurs 
earlier in life and at earlier stages of the disease. They also reported 
higher level of dyspnea measured by the modified medical research 
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council scale than men with same degree of airway impairment. Women 
also have worse scores in all domains of the St. George‘s Respiratory 
Questionnaire (SGRQ) thus have a lower quality of life. This may be 
due to.  
1.   The experience of dyspnea has cognitive, affective and physical 
dimensions, meaning impact of dyspnea not only related to the degree of 
lung impairment but to the patients emotional response to  and higher 
interpretation of sensation. For example, limitation in exercise 
performance causes more distress than the sensation of dyspnea itself.  
2.  Women have higher intrinsic sensitivity to noxious stimuli including 
dyspnea. Neuroimaging studies reveal gender differences in the 
laterality of prefrontal cortical processing of noxious stimuli.  
3.  Women have greater awareness and attention to somatic sensations than 
men, making them more likely to sense dyspnea. 
4.  They tend to have lower inspiratory muscle strength 
5. Women have higher rate of bronchial hyperreactivity, it is also an 




Biomass exposure - a significant risk factor in women 
About two third of rural India use biomass fuel for cooking. Combustion 
of biomass fuels is the most important source of indoor air pollution in 
developing countries. A recent meta-analysis has shown that biomass fuel 
exposure is associated with a significant risk of chronic bronchitis and COPD 
and the strength of association similar to that of cigarette smoking [12]Those 
exposed to wood smoke having the greatest effect (relative risk 4.3) compared 
with animal dung / crop residue (relative risk 2.5) and coal / charcoal (relative 
risk 1.5-1.8). 
 Indoor air pollution due to biomass is ranked 10th  among most 
preventable risk factor for global disease burden. Biomass smoke is a complex 
mixture of hundreds of volatile and particulate matter including organic and 
inorganic compounds and more than 90% are in the respirable range of less 
than 10 microns. The most important toxic constituents are solid particulate 
matter (PM10 and PM2.5), carbon monoxide, nitrogen and sulphur monoxides, 
aldehydes such as formaldehyde, polycyclic aromatic hydrocarbons such as 
benzopyrene, volatile organic compounds and free radicals. 
 Cooking results in significant emissions the mean 24h PM10  may range 
from 300 to 3000mcg/m3 and may reach upto 30,000mcg/m3 . The mean 24 h 
carbonmonoxide ranged from 2 – 50ppm and may reach upto 500ppm . A study 
from Colombia found that biomass stove use for 10 or more years was 
associated with a greater risk of COPD as defined by a postbronchodilator 
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FEV1/FVC ratio less than 0.70 (GOLD stage 1 or greater; OR, 1.5; 95% CI, 
1.22–1.86)[13] . Behera et al’developed a simple , easily applicable ‘biomass 
exposure index ‘ that was calculated by multiplying the hours spent on cooking 
per day and number of years of cooking [14] to calculate the intensity of 
exposure. P.A.Mahesh et al demonstrated that a minimum threshold of biomass 
exposure index of 60 necessary to have a significant risk of developing chronic 
bronchitis.[14] 
 
FIG; 1(a) Linear regression plot of increasing biomass smoke exposure 
and log odds of chronic bronchitis among women in rural Mysore 




The type of housing and ventilation play a role in level of exposure to 
particulate matter. In rural India most of the houses are mud houses with no 
separate kitchen and poor ventilation with no windows let the combustion 
particles settle in the household leading to high exposure. And also due to lack 
of space / rooms sleep and spend time in the same room increasing the hours of 
exposure. An interventional trial in Mexico showed significant attenuation 
in”“FEV1 and fewer respiratory symptoms with the use of improved cooking 
stoves.[16] 
Childhood exposure to biomass is an added risk factor for the 
development of COPD. The developing lung is highly susceptible to damage 
from exposure to PM particulate matter from biomass fuel combustion. School 
children in rural India, where use of biomass is common have a significant 
reduction in lung function and increased bronchial hyper reactivity. Grigg et al 
2009, showed a direct link between childhood exposure to PM of biomass and 
development of COPD in non cigarette smoking women.[17] 
Nutritional status of women  
Nutritional status is mainly evaluated by BMI. Charlotte Landbo et al  
in his analysis over 17 years showed an independent effect of BMI on survival, 
with significantly higher mortality seen in underweight subjects than in those 
of normal weight. In subjects with mild or moderate COPD, the associations 
between BMI and mortality did not reach significance, but the relation tended 
to be U-shaped. The impact of BMI on COPD mortality was stronger than that 
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on all-cause mortality, with RRs between the lowest and highest BMI of 5.56 
(range: 2.47 to 12.54) and 7.17 (range: 2.45 to 21.00) in men and women, 
respectively. [18] 
The body mass is divided into two compartments, one called fat mass 
and the other fat free mass with the latter to contain the main metabolically 
active organs particularly skeletal muscle mass. This might be attributed to the 
fact “that loss of skeletal muscle mass is the main cause of weight loss in 
COPD, whereas loss of fat mass contributes to a lesser extent, leading to the 
plausible theory that FFMI reflects better the muscle mass than BMI. Low 
FFMI is significantly correlated with severity of COPD. Thus, an important 
issue is to explain why the skeletal muscle mass diminishes as the disease 
progress while it remains stable in early stages. This might be attributed to the 
high rest energy expenditure due to increased work of breathing in combination 
with inadequate dietary intake, to physical inactivity due to exercise 
intolerance, to excessive apoptosis of skeletal muscle due to increased systemic 
inflammation, and/or to the presence of hypoxia and the more frequent use of 
systemic corticosteroids.[19] 
Smoking status of Indian women 
Cigarette consumption in India is falling steadily even as the number of 
women smokers is rising, making it home to the second largest number of 
female smokers after the United States. According to the latest data on cigarette 
consumption given by the health ministry in Parliament, showed that the 
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number of women smokers in India went up from 5.3 million in 1980 to 12.7 
million in 2012. According to a 2009-10 survey by the health ministry on 
tobacco smoking among Indian men and women were 15% and 2% 
respectively. About 9% of men and 1% of women both chew tobacco and 
smoke it. [20] 
Long standing asthma and the risk of COPD 
Chronic airway obstruction is persistence of airway obstruction( low 
FEV1) inspite of pharmacological attempts at reversal. Longer duration of 
asthma may lead to severe airway obstruction. Asthma is associated with 
additional decline in FEV1 than normal. Low baseline lung function, less 
response to beta agonists, severe bronchial hyperresponsiveness, male sex, 
mucus production and frequent exacerbations all lead to persistent airflow 
limitation.  
In childhood asthma, wheezing between the ages of 3 and 6 (Tucson 
study), severe bronchial hyperresponsiveness, early onset of respiratory 
symotoms, severe respiratory symptoms, female sex, persistent wheezing all 
lead to low FEV1 in adulthood.[21] 
CT scan revealed bronchial wall thickening in asthmatic patients with 
irreversible airway obstruction. When emphysema features are seen in 
asthmatics with irreversible airway obstruction, have longer duration of disease 
and increased asthma severity. It still remains unclear whether asthmatics with 
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airway obstruction meeting GOLD spirometric criteria are pathologically and 
phenotypically similar or different from COPD. 
Outdoor air pollution as a risk factor 
Outdoor air pollution is a mixture of  hundreds of pollutants that 
originate from traffic, industries and other sources. There are evidences that 
living near busy roads leads to exposure to particulate matter, O2 and NO2 lead 
to deleterious effects on the airway due to airway oxidative stress, systemic.” 
and “pulmonary inflammation. Reduced ciliary activity, amplification of viral 
infections and increase in bronchial hyper reactivity. Biological plausibility is 
provided by the observation between black carbon content in resoiratory 
macrophages and decreased pulmonary function growth. It occurs during our 
entire life span and may lead to irreversible airway obstruction and COPD. 
There is evidence that daily variation in outdoor air pollution can lead to 
exacerbation of COPD. The German SALIA study showed higher PM10 in the 
environment lead to increase in COPD prevalence [22]. Many studies present 
strong evidence of an association between outdoor air pollution and decreased 
pulmonary function during childhood and adolescence.  
Second hand smoke as a risk factor for COPD  
Exposure to secondhand smoke (SHS), which contains potent 
respiratory irritants, may lead to chronic airway inflammation and obstruction 
s. Biological plausibility is supported by the presence of numerous airway 
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irritants contained in tobacco smoke and the strong relationship between direct 
smoking and COPD. Rachel E Jordan et al showed that never smokers having 
clinically significant COPD, where never smokers exposed to between 1 and 
19h of passive smoking in a week had a 52% excess risk and those exposed to 
>20h had an excess risk of 98%.[23] A study from China found that self-
reported cumulative lifetime SHS exposure at home and work was related to a 
greater risk of COPD, as defined by spirometry (GOLD stage 1 or 
greater).[24]“Another study showed that living with a smoker was associated 
with a greater risk of a physician diagnosis of COPD.[25] 
Occupational exposure as a risk factor for COPD 
A diagnosis of ‘‘occupational COPD’’ is rarely made by clinicians; this 
situation is in sharp contrast to occupational asthma, which is more frequently 
recognized. The demonstration of an association between occupational 
exposures and COPD in epidemiological studies can be difficult because of 
several factors. First, COPD is multifactorial in etiology, with critical (and 
mostly unknown) host as well as nonoccupational environmental determinants 
of risk. Second, unlike workers with pneumoconioses, individuals with COPD 
due to occupational exposures cannot be distinguished from those with the 
disease due to other causes. Third, many workers with COPD have concurrent 
exposure to cigarette smoke (direct and/or secondhand smoke) and workplace 
irritants. Fourth, exposed workers at baseline tend to have better overall health 
and pulmonary function than the general population, the so-called healthy 
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worker effect. Fifth, workforce studies are often limited to a ‘‘survivor’’ 
population because of inability to assess or monitor workers who leave their 
jobs, thereby underestimating the chronic effects of occupational exposures. 
 It has been estimated that 15% of COPD is attributable to occupational 
exposure. Vapors, gas, dust, and fume exposures have been shown to be 
associated with COPD among workers in various occupations and industries. 
Exposure to organic, inorganic dust, and sensitizing agents in agricultural and 
food workers shows higher prevalences of respiratory conditions including 
COPD morbidity and mortality. Chronic exposure to coal and silica dust 
increases risk of COPD among miners. The dusts from coal, stone quarries, 
wood, cereals and agricultural work, animal stables, textiles, and paper 
production that can arise in occupational environments have been regulated by 
the International Labor Organization and considered possible as contributors to 
COPD. 
 Among construction and extraction workers, the odds of having chronic 
bronchitis were 1.4 times that of workers in management occupations, 
indicating that there are factors associated with construction and extraction 
work.[26]. Doney et al in the National Health Interview Survey Data 2004 to 
2011, showed that females had a higher prevalence than males, which is 
consistent with findings reported by Ford et al.[27][28] Various factors have 
been associated with higher COPD among women, some of which are 
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environmental tobacco smoke, biological differences, occupational exposure, 
or a combination of all these factors.  
Low socioeconomic status as a risk factor 
Socioeconomic status is a total measure of an individual’s or family’s 
economic and social position in relation to others. Poor housing conditions and 
home dampness with increased house dust mites and biomass usage are all 
associated with respiratory symptoms, reduced lung function, and lower 
socioeconomic status. Household crowding has been hypothesised to cause 
increased instances of respiratory infections and thus increased rates of 
respiratory disorders, although this was not confirmed in the Tucson study. 
Bakke et al. have showed that low educational level is an independent 
determinant for COPD.[29]  Individuals of the lowest socioeconomic strata 
were at least twice as likely to have poor outcomes as those of the highest 
(range from no difference to 10-fold difference). Gershon et al showed 
evidence that social and economic disadvantage appears to have a significant 
consistent impact on COPD mortality and morbidity.[30] 
Asthma COPD Overlap Syndrome ( ACOS ) 
Asthma COPD overlap syndrome is a heterogenous disease 
characterised by persistent airflow limitation showing several features which 
has association with both asthma and COPD. They are usually above 40 years 
of age with respiratory symptoms that may or may not present in childhood 
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with persistent airflow limitation showing partial reversibility. Joan B 
Sorianoet al.[31]studied data from a very extensive population and reported 
that 19% patients with obstructive lung disease had a concomitant diagnosis of 
asthma, chronic bronchitis or emphysema. Similarly, S E March et al.[32] in a 
total of 469 patients reported that 55% of the population studied had asthma as 
the predominant COPD phenotype. 
   There are two well-known hypotheses, the “Dutch hypothesis” 
suggests that COPD and asthma are the same basic disease process and that 
long standing asthma predisposes to COPD and the “British hypothesis” that 
“proposes COPD and asthma are distinct entities and that both diseases coexist 
separately within the same individual. 
   Marco R et al.[86] in a survey of Italian patients revealed that in those 
diagnosed with asthma, 16-61% also had ACOS and those diagnosed with 
COPD, 25-33% also had ACOS. Soriano et al.[26] reported that an estimated 
23% COPD subjects between ages 50 and 59 possibly has a mixed phenotype. 
With an increase in age to 70-79.4, the percentage increased to 52%. In the 
EPISCAN epidemiological study where bronchodilator test was used as a 
reference, 31.5% of the COPD patients had a positive test. Hence, from the 
above data, it can be concluded that between 20-50% of COPD patients may 




Radiological presentation of female COPD patients 
Pat G.Camp et al found that participants exposed to biomass smoke had 
less emphysema, based on both qualitative and quantitative CT measures, than 
those exposed to tobacco smoke He also noted that predominance of airway 
wall thickening with predominant airway phenotype in biomass exposed 
women. The radiologists’ rating also showed worse air trapping in women 
exposed to biomass smoke.[34] Several mechanisms may be responsible for the 
phenotypic differences between exposure groups observed in this study.  
First, differences in chemical composition of biomass and tobacco 
smoke could lead to different pathophysiological processes. Secondly, biomass 
exposure in rural villages can begin in utero, and individuals are often exposed 
throughout their lives, with women receiving the largest cumulative exposures  
may predispose  to a different COPD phenotype as adults, compared to tobacco 
smokers who may begin smoking at an older age. Thirdly, there are possible 
differences in the inhalation pattern individuals inhaling biomass smoke would 
use a consistent tidal breathing pattern. Conversely, cigarette smokers usually 
smoke in a two-phase pattern: first the smoke is drawn into the mouth without 
direct inhalation into the lungs, then the smoke is inhaled into the lungs with an 
additional volume of air. This leads to deposition of particles in airways in 
biomass exposed individuals producing airway predominant phenotype as 
opposed to tobacco smoke exposed individuals where it gets deposited more 
peripherally and producing emphysema predominant phenotype. In addition, 
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the radiologists indicated the presence of bronchiectasis in the scans of 14% of 
the participants exposed to biomass smoke compared to 0% of those exposed to 
tobacco smoke (p=0.009). [34] 
Severity of symptoms by CAT score. 
CAT scores in women 
The COPD assessment test is a short and simple ( set of 8 questions ) 
completed by the patient which aim to assess the impact of cough, sputum, 
dyspnea, chest tightness on the health status of the patient due to COPD. It has 
a high  correlation with SGRQ (r=0.84) which is a validated score to assess the 
quality of  life. Higher scores denote a more severe impact of COPD on a 
patient’s life. The difference between stable and exacerbation patients was five 
units. 
As women tend to have a lower quality of life, they have a higher CAT 
score. The CAT questionnaire in spite of having small number of components, 
cover broad range of health effects of COPD on health. ,  
FIG 2 : The Bland and Altman plot  showed a very stable relationship across the 
scaling range between CAT score and SGRQ score[35] 
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At the mild end of the CAT scale the score slightly over-estimated 
severity by a small amount (SGRQ = 0, adjCAT = 5, equivalent to 2 CAT units) 
and at the severe end it slightly under-estimated severity (SGRQ = 100, 
adjCAT = 92.5, equivalent to 37 CAT units). This level of agreement was 
sufficient to permit direct mapping between SGRQ and CAT scores. [35] 
Impact of CAT score on degree of airflow limitation. 
The relationship between CAT score and FEV1% predicted suggests 
that CATscore is linked to severity of airflow limitation and GOLD 
classification in stable COPD patients. There was a significant association 
between the FEV1% predicted and total CAT score (r= -0.55, p< 0.001).  
Health status as measured by CAT worsens with severity of airflow limitation.[ 
36 ] 
Paul W Jones et al(21) found patient centered assessment successfully 
graded COPD severity clinically and appeared to have greater discriminative 
power for assessing severity in COPD than FEV1 based staging. [37]. Sumer et 
al in his study had a significant correlation between CAT score and the stage of 
the disease (p = 0.004).[38]The number of exacerbations in the preceding year 
and FEV1 were independent predictors of the CAT score in the general linear 
model. During exacerbation, rises in CAT score were significantly associated 
with falls in FEV1(6) [ 39 ] 
Factors affecting severity of airflow limitation 
The impact of age on FEV1 was proven when  We Johannes et alstudied 
the incidence and significance of airflow limitation in a population-based 
geriatric sample using both an age-dependent predicted lower limit of normal 
(LLN) value and a fixed-ratio of < .70 spirometric criterion. The incidence 
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increased dramatically with age when using a fixed ratio, but less so when 
using LLN. In addition, a sex effect was observed with the LLN criterion. He 
found that female sex may be a risk factor for developing airflow limitation and 
consequently COPD. [40] 
Kurmi et al  observed ventilatory function (forced expiratory volume in 
1 s (FEV1), forced vital capacity (FVC) and forced expiratory flow at 25–75% 
of FVC) was significantly reduced in the population using biomass across all 
age groups compared to the non-biomass-using population, even in the 
youngest (16–25 yrs) age group (mean FEV1 (95% CI) 2.65 (2.57–2.73) versus 
2.83 (2.74–2.91) L; p50.004).[41] 
Mitra et al showed that mean BMI of stage 1 COPD subjects was 26.21, 
stage 2 was 22.91, stage 3 was 20.78, and stage 4 was 15.71. One-way 
ANOVA showed that BMI of the patients were decreasing with increasing 
severity of the disease (GOLD) and it was statistically significant (P< 
0.05). Thus found a positive correlation between severity of obstruction and 
BMI in COPD. [42] 
Banurekha B et al noted that mMRC dyspnoea scale correlated well 
with FEV1 post spirometric indices. D(P=0.0001)[ 43 ] 
Pulmonary Hypertension in female COPD patients 
 Pulmonary hypertension (PH) is a common and well established 
complication of chronic obstructive pulmonary disease (COPD). Its presence is 
associated with decreased survival. The pathophysiology of the development of 
PH in COPD is poorly understood and is likely multifactorial. Morphologic 
changes in the pulmonary arteries are initiated by the toxic effects of tobacco 
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and biomass smoke and progress in parallel with the parenchymal changes of 
COPD. An endothelium-derived vasoconstrictor-dilator imbalance, mainly 
from a decreased endothelial nitric oxide expression, increased vascular 
endothelial growth factor and serotonin transporter expressions have also been 
implicated in the pathogenesis of pulmonary hypertension. Sertogullarindan et 
al in their study sex had highest value of OR for PH in moderate and very 
severe COPD cases and posed that biomass smoke has a greater risk for PH in 
women and also suggested a predisposition to PH in females. [105] 
Common co-morbidities in female COPD 
It has been observed in the ECLIPSE study that comorbidities were 
significantly higher in patients with COPD than in smokers and never smokers 
[44]Dal NegroRW et al assessed that the overall prevalence of co morbidities 
was 2.6 per patient with 2.5 in males and 3.0 in females.( p<0.05).[45]The 
important comorbidities associated with COPD are cardiovascular disorders 
(coronary artery disease and chronic heart failure, hypertension), metabolic 
diseases (diabetes mellitus, metabolic syndrome and obesity), bone disease 
(osteoporosis and osteopenia), stroke, lung cancer, cachexia, skeletal muscle 
weakness, anaemia, depression and cognitive decline. [46] Cardivascular 
disorder was more common in males whie metabolic, digestive and 
osteoarticular disorder more frequent in females. 
Diabetes in female COPD patients.  
Diabetes affects 2–37 % of patients with COPD. women with pre-
existing asthma or COPD had a higher risk of developing type 2 diabetes, 
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independently of traditional diabetes risk factors including cigarette smoking 
chronic airway inflammation may increase the risk of type 2 diabetes through 
underlying proinflammatory mechanisms. Elevated circulating levels of certain 
inflammatory cytokines caused by chronic airway inflammation may also 
contribute to the development of insulin resistance in the liver, skeletal muscle, 
and vascular endothelium, ultimately leading to the clinical expression of type 
2 diabetes.[47] 
The average rate of decline in lung function in diabetes mellitus patients 
with history of no lung disease, as measured by FEV1 was 71 ml/year 
compared to an expected decline in healthy non-smokers of 25–30 ml/year, The 
lung function decline in patients with diabetes may be a consequence of 
diabetes itself and diabetic patients seem to have an increased risk of several 
non-neoplastic lung conditions such as  COPD [48] 
Hypertension in female COPD patients. 
Augusti A et aland Sin DD et al noticed that Reduced FEV1 nearly 
doubles the risk for cardiovascular mortality independent of age, sex and 
cigarette smoking.[44, 49] AnthonisenNR et al reported that a 10 per cent 
decrease in FEV1 among COPD patients increases the cardiovascular event 
rate 28 per cent. [50] 
Curkendall SM et al showed COPD patients were 1.76 times more likely 
to have arrhythmias, 1.61 times more likely to have angina, 1.61 times more 
likely to develop acute myocardial infarction and 3.84 times more likely to 
develop congestive heart failure. [51] DeLucas Ramos et al in their multivariate 
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analysis adjusted for the remaining factors, COPD was still an independent risk 
factor suggesting that COPD patients had a high prevalence of cardiovascular 
disease, higher than expected given their age and the co-existence of classic 
cardiovascular risk factors [52] 
Depression in female COPD patients 
Patients with COPD, particularly severe COPD, were at an increased 
risk of developing a diagnosis of incident depression.  A wide range of 
depression prevalences in patients with COPD from 7% with an FEV1 < 80%, 
up to 79.1% in patients with COPD with chronic respiratory failure. This is in 
accordance with Van Mannen et al study.[53]Schneider et al in his study 
noticed that  the relative risk estimate (odds ratio [OR]) of developing an 
incident depression diagnosis for patients with COPD was 1.44 (95% CI, 1.30–
1.60),  The cumulative incidence has recently been reported to be 6.1%.[54] 
The assessment of the impact of depression in COPD is complicated by 
a two-sided association; depression is believed to Patients with COPD, 
particularly severe COPD, were at an increased risk of developing a diagnosis 
of incident depression. 
Depression contribute indirectly to the development of COPD as 
depressed people are less likely to quit smoking, but depression can also 
develop as a direct or indirect consequence of a COPD diagnosis. Anxiety and 
depressive symptoms are common in patients affected by COPD, even when 
their disease is mild in terms of FEV1 and respiratory symptoms. 
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Female patients appear to be more susceptible to psychological 
impairment, which correlates with some specific symptomatic aspects of the 
disease, such as dyspnea. These aspects have greater importance in view of the 
rising prevalence of COPD in females. Psychological aspects need to be 
carefully assessed in COPD patients, particularly in females. Dyspnea more 








AIMS AND OBJECTIVES 
Primary Objectives 
1. To study the prevalence of severity of airway obstruction, 
sociodemographic, clinico-radiological profile in female Chronic 
Obstructive Pulmonary Disease.  
2. To assess the correlation of COPD assessment test (CAT) and degree of 
airflow obstruction in Chronic Obstructive Pulmonary Disease in 
females. 
Secondary Objectives 
1. To also assess the correlation between sociodemographic and 





















      












ALGORITHM SHOWING SAMPLING METHOD ADOPTED 
113 female patient above 40 years with respiratory symptoms with chronic 
cough,sputum,breathlessness and with post-bronchodilator ratio FEV1/FVC  
<0.70(according to GOLD) presenting to thoracic medicine OPD in 
RGGGH,Chennai and ITM,chennai 
 
EXCLUSION CRITERIA 
 Presence of active tuberculosis / Treated 
pulmonary tuberculosis 
 Relative Contraindications for Spirometry like 
recent history of myocardial infarction, history of 
recent upper abdominal/thoracic surgery/cataract 
surgery, history of hemoptysis 
 Psychiatric diseases other than depression 
 Patients with significant cognitive impairment 
 Those with disabling loco motor diseases and 
bed ridden patients were not included in the 
study 
 Patients not consenting for the study 
91 female patients  
were finally included in the study 




MATERIALS AND METHODS 
Study design:   
 The study was a cross sectional observational study. 
 No specific intervention was done. 
 Patients were included in the study through random selection.  
 No specific method of randomisation was used. 
 No controls were used in the study 
Study period:   January 2016 to August 2016 
Study centre:  Thoracic medicine outpatient department at,  
1. Rajiv Gandhi Government General Hospital. 
2. Institute of Thoracic Medicine, Chetpet. 
Subject selection 
Inclusion criteria: 
(As per GOLD Guidelines 2016, Female COPD suspects criteria)[56] 
Female patients more than 40 years of age with clinical history and symptoms 
suggestive of COPD for more than 8 weeks 
 Dyspnoea: Progressive (worsens over time), Characteristically worse 
with exercise 
 Chronic cough: Intermittent and productive or unproductive 
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 Chronic sputum production 
AND 
 Spirometric diagnosis of COPD according to GOLD guidelines 2016 
with post bronchodilator FEV1/FVC under 0.70 [56] 
Exclusion criteria 
• Presence of active tuberculosis / Treated pulmonary tuberculosis 
• Relative Contraindications for Spirometry like recent history of 
myocardial infarction, history of recent upper abdominal/thoracic 
surgery/cataract surgery, history of hemoptysis 
• Psychiatric diseases other than depression 
• Patients with significant cognitive impairment were also not included 
as we needed our study patients to fill questionnaires. 
• Besides since we needed our study patients to undergo six minute 
walk test, so those with disabling loco motor diseases and bed ridden 
patients were not included in the study. 
• Patients not consenting for the study. 
Sample size: 
• 91female patients who satisfied the inclusion and exclusion criteria 





The following were assessed in our study in patients with Chronic 
Obstructive Pulmonary Disease (COPD) 
 History of presenting symptoms 
 Severity of symptoms 
 Socioeconomic status 
 Risk factor assessment 
 Nutritional status 
 Presence and severity of depression 
 Degree of airflow obstruction and reversibility 
 Exercise capacity 
 Radiological presentation 
History of presenting symptoms 
• History of cough, sputum production, breathlessness and wheeze 
their duration taken. 
• Previous history of exacerbations and hospitalization in the past 1 
year ( exacerbations when patient needed to attend a health care unit 
because of symptoms which lead to increase in dose or addition of an 
antibiotic ) 
Severity of symptoms 
Severity of symptoms as perceived by the patient was measured using 




COPD Assessment Test (CAT) : 
The COPD Assessment Test (CAT) is a Patient-completed 
questionnaire assessing the impact of COPD on health status .Validation 
studies show that CAT has propertiesvery similar to much more complex 
health status questionnaires such as the St George’s Respiratory Questionnaire 
(SGRQ).[57] It consists of 8 questions each presented as a six-point (0-5) 
differential scale with a total score out of 40.It is available in 66 different 
languages. Tamil version of the document was used in our study. 
The clinical impact of the disease is graded as follows: Table 1 
 
Modified Medical Research Council grades (mMRC) 
We used the modified medical research council scale of dyspnea to 
assess  the severity of dyspnea. It quantifies the disability associated with 
breathlessness by identifying when breathlessness occurs (Grades 0 and 1) or 
by quantifying the associated exercise impairment (Grades 2–4). [58]The 
grades correlate well with other dyspnoea scales, lung function 
measurements[59] and with objective measures of disability such as six minute 
walking distance.[60] 
The mMRC grades were self-administered asking patients to choose the 
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The most widely accepted scale for urban populations has been 
proposed by Kuppuswamy in 1976 . We used Modified Kuppuswamy’s 
Socioeconomic Scale.[61] 
Table 3  Kuppuswamy’s Socioeconomic Scale 
EDUCATION  OF HEAD SCORE 
1.Profession or Honours  
2. Graduate or post graduate  
3. Intermediate or post high school diploma 
4. High school certificate  
5. Middle school certificate  









OCCUPATION OF HEAD SCORE 
1. Profession  
2. Semi-Profession  
3. Clerical, Shop-owner, Farmer  
4. Skilled worker 
5. Semi-skilled worker  












FAMILY INCOME PER MONTH 
[ In Rs/month] 
SCORE 
 
1 . ≥                  41,796                   
2. 20,898  -       41,795                   
3. 15,674  -       20,897                      
4. 10,449  -       15,673                    
5. 6,269    -       10,448                   
6. 2,111    -       6,268                      






















Risk factor assessment 
• Severity of smoking 
If history of smoking was present, the severity was graded with 
smoking index for number of beedis/cigarettes smoked. 
Smoking index is calculated as the product of number of cigarettes 
or bidis smoked per day and the duration of smoking habit in years.  
Table :4  Severity of smoking based on Smoking Index [63] 















• Biomass exposure 
 
Information was collected regarding type of  Biomass fuel exposure and 
duration of exposure. Number of years of exposure / Number of hours spent 
on cooking everyday personally. Then  Biomass exposure index was 
calculated as the average number of hours spent on cooking daily for 
cooking multiplied by the total number of years spent in cooking 
personally.[14]As minimum threshold of biomass exposure index of 60 was 
necessary to have a significant risk of developing COPD was identified by 
Mahesh P et al we divided the study group as follows [15] 
Table: 5   Severity of biomass exposure 
Severity of biomass exposure Biomass exposure index 
No exposure  0 
Exposure less than threshold < 60 
Exposure above the threshold > 60 
 
 History of Biomass Exposure during childhood less than 15 yrs was 
also obtained.[64] 
 History of lower respiratory infections in childhood [65] 
 History of physician diagnosed asthma and duration- the patients 
were divided into 3 categories as no asthma, history of asthma for 
more than 10 years and history of asthma for less than 10 years [66, 
67] 
 Family history of COPD-  This history was not reliable as most of 
them were not sure about the diagnosis in the relatives and could not 
provide proof regarding the diagnosis[68] 
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 Occupational history- Information was collected on Occupational 
exposure to dust/fumes and duration of exposure.[69,70,71,72] 
 Type of housing and living conditions - Type of housing – Thatched/ 
Tiled/ Concrete/ others, and whether it has separate kitchen or not/ 
whether it was the only room in the house/ regarding ventilation with 
windows and vent for the escape of biomass combustion 
products.[41] 
 Whether the locality of the house is near to busy road with heavy  
traffic of motor vehicles including buses and lorries.[22] 
Presence and severity of depression: 
The presence and severity of depression in our study subjects was 
assessed  using Patient Health Questionnaire – 9.Patients Health Questionnaire 
is a tool used worldwide for screening, diagnosing, monitoring and measuring 
the severity of depression. It is a simple tool that can be filled by the patients 
within minutes. The questionnaire has been shown to have good 
reproducibility. The questionnaire has 9 questions. Each question is scored 
from 0 to 3. Thus the total score of the tool ranges from 0 to 27. The 9 
questions actually represent the 9 criteria used to diagnose depression as per 
DSM-IV.[73] PHQ-9 score of greater than 10 has the sensitivity and specificity 
of 88 % in diagnosing major depression. The Patient Health Questionnaire has 
been internationally validated for the purpose of identifying and grading the 
severity of  depression. [74] PHQ-9 score of 4 is considered to be the upper 




Table 6: Interpretation of PHQ-9 score in grading severity of depression 
Nutritional Status of the patient: 
The nutritional status of the patient was measured using Body Mass 
Index and Fat Free Mass. 
Body Mass Index: 
Body Mass Index (BMI) was calculated from the height and weight of 
the patient  using the formula BMI = Weight in kg / (Height in m)². 
The patients were classified based on the BMI as given in Table 8 as per 
WHO recommendations
 




Fat Free Mass (FFM): 
Fat Free Mass has been shown to be a better indicator of nutritional status of an 
individual than Body Mass Index particularly in patients with COPD. [76] 
Though there are different methods to measure Fat Free Mass like 
We used the method of skin fold thickness in our study. The skin fold thickness 
was measured using adult skin callipers 4 different sites 
 Front of arm 
 Back of arm 
 Below the scapula 
 At the level of hips 
Body density was calculated from skin fold thickness using  
Durnin and Womersley equations as shown in the table: 7 
Table 8: Body density equations of Durnin and Womersley (D = Body density, 
L = Skin Fold Thickness) 
Body Fat percentage was then calculated using Siri Equation and Fat 
Free Mass was derived from it [78] 
% Body Fat = (495 / Body Density) – 450 




Pulmonary Function Test: 
Spirometry  was done for all patients who satisfied the inclusion criteria. 
It was done as per the American Thoracic Society recommendations using 
Easyone Spirometer. [79]The instrument was calibrated daily. The procedure 
was explained to all patients before the test. Any recent history of illness, 
medication were enquired and the height and weight were recorded. The 
appropriate technique of spirometry was demonstrated to each patient 
individually before the start of procedure. The patients were asked to inhale 
rapidly and completely from Functional Residual Capacity (FRC). The patients 
were instructed to hold the mouth piece in their mouth, sealed tightly by their 
lips. Patients were asked to blast out air without any hesitation and were asked 
to completely exhale. Throughout the procedure, patients were coached using 
body languages and phrases. The testing was done in sitting position and  nose 




Fig 3: Acceptability and repeatabilitycriteria as per ATS guidelines 
 
Measurements were made before and after atleast 15 minutes of two 
puffs of salbutamol (200μg) administered using metered dose inhaler with a 





Table:9Severity of airflow limitation as per GOLD guidelines 
 
Exercise capacity: 
Exercise capacity was measured using six minute walk test 
(6MWT).The six minute walk test was done as per the American Thoracic 
Society recommendations.[80] The test was performed indoors in a 100 ft 
hallway (30 m length). The length was of the hallway was marked every 3m as 
well as the starting and ending point of each 60m lap. The turnaround points 
were marked with two small cones. The patients were asked to wear 
comfortable dresses and foot wear. They were asked to continue their usual 
medications. They were asked to avoid heavy meals before the test or indulge 
in any strenuous physical activity before 2 hours of beginning the test. The 
patients were instructed to rest for 10 minutes in a comfortable chair before 
beginning the test. During this period their vitals were measured. The patients 
were then instructed to walk as far as possible in six minutes. They were 
allowed to slow down or rest and then continue the test if needed. A visual 
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demonstration of the test was given before starting the tests. Post testing, the 
patients were made to relax and vitals 
monitored again. The distance covered by them in 6 minutes was measured in 
metres. The expected six minute walk distance was calculated for each patient 
using the following regression equations42 based on their sex, based on their 
sex, age ( in yrs), height (in metres), weight (in Kgs). 
The reference equation in females [81] 
256.8 + [2.4 X Height] – [1.5 X Age] – [0.3 X weight] 
The six minute walk distance of each patient was expressed as 
percentage of the expected, calculated as 
               Observed value / expected value x 100 
The severity of impairment of exercise capacity was arbitrarily graded as in 
Table 10: Interpretation of impairment of exercise capacity using 6MWT 
distance 
 
GOLD combined assessment of patients with COPD: 
A new method for classification of COPD patients has been proposed by 
GOLD. [56] It takes into account 2 factors 
 Level of symptoms by either of 
o MMRC grade 
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o COPD Assessment Test score 
 Risk of exacerbations by either of 
o GOLD classification of airflow limitation 
o No of exacerbations in the preceding one year 
The GOLD combined assessment of patients reflects the complexity of 
COPD better than the unidimensional analysis of airflow limitation previously 
used for staging the disease is given in Fig 4 
 
 
GOLD Combined Assessment classification of patients with COPD [56] 
Group A   -    Less symptomatic, Low risk 
Group B   -   More symptomatic, Low risk 
Group C   -   Less symptomatic, High risk 





An HRCT chest was taken for all patients included in the study. 
Following an initial conventional helical scanning for screening, an HRCT was 
done in full inspiration at 1mm slices. Four slices of 1 mm thickness were 
obtained at the following levels: 
1. Superior margin of aortic arch (level of upper lung) 
2. Level of carina (level of middle lung) 
3. Level of inferior pulmonary veins ( level of lower lung) 
The window levels were set from -700 to -900HU which was appropriate for 
the lungs.[83]Table 11 
 
The low attenuation area (LAA) was measured by the visual assessment 
in bilateral lung fields according to the method of Goddard.[84] The total 
scores and grade of emphysema was calculated as follows: table 12. 
  
SCORE LAA PERCENTAGE 
0 LAA <5% 
1 5% ≤ LAA <25% 
2 25% ≤ LAA <50% 
3 50% ≤ LAA<75% 
4 75% ≥ LAA 
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Bronchial wall thickness was assessed visually as follows: Table 13 
GRADE BRONCHIAL WALL THICKNESS 
1 NONE 
2 <50% adjacent pulmonary artery 
diameter 
3 >50% adjacent pulmonary artery 
diameter 
 
Based on the visual HRCT assessment, patients were classified into 
three phenotypes as follows:  
1.  Absence of emphysema, which showed little emphysema and LAA ≤ 
grade 1 with and without BWT (A phenotype)  
2.  Apparent emphysema ≥ grade 2 without BWT (E phenotype)  
3.  A combination of apparent emphysema = grade 2 and BWT of more 
than grade 1 (M phenotype)   
Routine investigations including: 
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1.  Chest X ray PA view 
2.  Hemogram    
3.  Plasma absolute eosinophil count 
4.  Random Blood Sugar 
5.  HIV antibody testing were done for all patients. 
6.  Sputum examination for acid fast bacilli 
7.  Electrocardiogram 
8.  Echocardiogram 
STATISTICAL ANALYSIS:   
The data collected was entered in to Microsoft (MS) excel worksheet 
and analyzed using Statistical   Package   for   Social   Sciences   (SPSS) 
software version 16.0. Results were subjected for appropriate statistical 
analysis.All quantitative variables were expressed as mean & standard 
deviation for normally distributed data and median & inter quartile range for 
skewed data. All qualitative variables expressed as percentages &proportions. 
The statistical   significance of association was tested using independent 
sample t – test or ANOVA for quantitative variables and Pearson Chi - square 
test for qualitative variables. The strength of association was expressed using 
Odds ratio, wherever applicable. Fisher’s exact test was used when the 
expected value of more than 25% of the cells were less than five. Mann 
Whitney U test or Kruskal-Wallis Test was applied when the variable is ordinal 
or when the quantitative data was not normally distributed. All hypotheses 




In the given study period, a total of 91 study subjects who satisfied the 
inclusion criteria were interviewed and their results are presented as follows. 
Age distribution 
The age group of patients in this study ranged from 41 to 73. The mean 
age of the study population was 56.63 with a standard deviation of 8.074. The 
number of patients in the age groups 41-50, 51-60, 61-70, and above 71 were 
30 (33.3%), 35 (38.8%), 24 (26.6%) and 2 (2.2%) respectively. 





Combination of cough, sputum and breathlessness reported by 32 
patients, presence of cough and sputum in 30 patients while combination of 
cough, breathlessness and wheeze least reported only in 2 patients. Cough is 
the most common symptom in 70 patients, while 67 reported sputum 
production too. 
Fig 6: Count of patients by symptoms 
 




Severity of symptoms of the study population 
CAT Score of the study population 
When the severity of symptoms assessed with COPD Assessment Test 
(CAT), it ranged from 7 to 33 with a mean of 24.43  + 6.55   Almost 97.8% of 
patients were in the more symptomatic group according to GOLD guidelines. 
Fig 8: Distribution of patients by CAT score 
 
Severity of symptoms based on mMRC grading of dyspnea 
The severity of symptoms such as breathlessness was assessed based on 
mMRC grading of dyspnea. Of the 91 patients, no one reported grade 0, while 
the majority had grade 2 or 3 of mMRC of dyspnea. The number of patients 





Fig 9: Distribution of patients based on mMRC grading of dyspnea 
 
Degree of airflow limitation in study population 
Airflow limitation assessed based on post bronchodilator FEV1% 
predicted as in GOLD guidelines. In our study population no patient was in the 
mild category (> 80% predicted). 4 of them were in the very severe category  
(< 30% predicted), 29 were in the severe airflow limitation category (30 to 50% 
predicted) and majority i.e., 58 were found to have moderate degree of airflow 
limitation(50 to 80% predicted). The mean FEV1 of the study population was 




Fig 10: Distribution of patients by airflow limitations (FEV1) 
 
Exacerbations and hospitalisation in the study population 
 In our study population 53 of them reported exacerbations in the last 
one year and 15 of them also had h/o hospitalisation in the last one year. Of the 
53 patients, 30 (32.9%) of them had more than one episode of exacerbation. 
We can see that 35 (38.1%) of the patients are in the high risk category based 
on hospitalisation and frequency of exacerbations.  




Fig 12: Hospitalization status 
 
GOLD Combined Assessment Test stratification of study population 
Our study group was classified based on GOLD combined assessment 
test as it is able to stratify whether our population is at high risk or low risk and 
also whether they were less symptomatic or more symptomatic. As the female 
population had high CAT score / higher mMRC grading of dyspnea , most of 
them almost 92.3% belonged to either B or D . Since most patients had more 
than one exacerbations, 49 (53.8%) belonged to the more symptoms and high 
risk group D. 35(38.4%) of them belonged to the more symptoms and less risk 
group B.We can see that 51 (56.04%) belong to the high risk group C and D.  




Fig 13: Distribution of patients by GOLD combined assessment test 
 
Nutritional status of the study population 
Body mass index of the population 
The body mass index of  the study population was calculated by 
measuring the height,  weight and using the Quetlet index. In this index the 
mean value was 22.37 kg/m2 and the standard deviation observed was 3.307. In 
the study population 62 of them were in the normal healthy BMI range and 
only 2 of them were in the obese range. 9 were underweight range in our study. 
The mean fat free mass of the study population was 31.87 kg with a standard 




Fig 14: Distribution of patients by Body Mass Index using Quetlet index 
 
Exercise capacity of the study population 
The exercise capacity of the study population was studied based on 6 
minute walk distance as recommended by ATS. As we divided the impairment 
based on 6MWD% arbitrarily into nil, mild, moderate and severe, no patient 
was in the severe group. Patients with nil impairment were 62, while 21 of 





Fig :15 Distribution of patients based on exercise impairment 
 
Socioeconomic status of the study population 
The socioeconomic status of the study population was assessed based on 
Kuppuswamy scale of socioeconomic status. Most of the study population was 
in the upper lower class, only 1 patient was in the upper middle class, 6 in the 
lower class and 9 in the lower middle class. The percentage of patients 
belonging tolower, upperlower, lower middle and upper middle are 6.5%, 
82.4%, 9.8% and 1.0% respectively. The mean income of the group was Rs. 
5365.9 with a standard deviation of 2727.65. The lowest income was Rs. 2000 




Fig 16: Distribution of patients by Kuppuswamy scale 
 
Educational status of the study population 
In our study population 57 did not know to read or write. Of the 
remaining 34 patients only 17 had completed primary education, 6 had 
completed SSLC and only 2 had done their PUC. 





Fig 18: Distribution of patients by school education 
 
Biomass Exposure of the study population 
In my study population of the 91 females, 73 had exposure to biomass 
fuel during cooking. Number of years of biomass exposure ranged from a 
minimum of 5 years to a maximum of 45 years with a mean value of 27.2 years 
in biomass exposed individuals. We also measured the biomass exposure index 
as suggested by Behera et al which is a more precise index of the intensity of 
exposure. It ranged from 0 to 161.As indicated by P.Mahesh et al( threshold for 
development of chronic bronchitis ) we divided the biomass exposure group 
into less than 60 and more than 60. 54 (59.3%) of our patients were in the high 
index group (>60) and only 19 patients in the low index group (<60), 
suggesting longer years / hours spent in cooking. We also saw adecrease in the 
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trend in the usage of biomass and shift to LPG usage due to free schemes by 
the government. 
Fig 19: Distribution of patients by Biomass exposure index 
 
Prevalence of smoking and second hand smoke exposure in our study 
group 
When we questioned about smoking only 3 females had accepted to 
smoking and all were in the moderate smoking index (100 - 300) group.. They 
were smoking around 8 to 15 cigarettes per day. In these 3 patients 1 had 
presented with lung cancer. 
On the other hand we found that 40 (44%) of our patients had exposure 
to second hand smoke. In these 40, for 32 patients their spouses were heavy 




Fig 20: Distribution in patients by prevalence of smoking 
 
Fig 21: Distribution in patients by exposure to second hand smoke 
 
Housing and ventilation 
In our study population 55 (60.4%) of them lived in thatched roof with 
no separate kitchen, 25 (27.5%) of them lived in tiled houses and 9 (9.9%) 
lived in concrete houses. Other 4 lived in sheet houses. In this group 65 
(70.3%) of them had no separate kitchen and with no windows and ventilation. 




Fig 22: Distribution of patients by housing and ventilation 
 
Environmental exposure due to nearness to busy road 
In our study population 40 (44%) of them lived on the main road with 
heavy traffic including buses. 





Prevalence of other risk factors in our study group 
Since exposure in biomass in childhood plays a role in airway 
remodelling and later might lead to respiratory diseases we found that 77 
(84.6%) had exposure to biomass fuel in less than 12 years. 
In our study group 26 (28.5%) of our patients gave history of infections in their 
childhood, had several hospital visits in their childhood.  
Fig 24: Distribution in patients by prevalence of other risk factors 
 
Work environment of the study population 
In our study group 35 (38.5%) of them were home makers, while the 
most common occupations were construction work and agricultural work, 17 
(18.6%) of them doing each work. 3 of them were in occupations involving 
handling flour, either packing or sieving. 5 (5.4%) were cooks, another 5(5.4%) 




Fig 25: Distribution of patients by work environment 
 
Asthma prevalence in the population 
History of physician diagnosed asthma was studied in our group.  64 
(70.3%) of them had no history of asthma. 14 (15.4%) of our patients gave 
history of asthma for more than 10 years and 13 (14.3%) gave history of 
asthma of less than 10 years. 




Significant reversibility in the population 
In our group 91 patients, 30 had a significant reversibility of 12% and 
200 ml in  FEV1 after a bronchodilator indicating an asthma overlap.  In these 
30 patients we further observed that 21 belonged to airway predominant ct 
phenotype and the remaining 9 were mixed phenotype. 






EOSINOPHILS REVERSIBILITY ON BRONCHODILATOR: 
The mean eosinophil % as well as AEC were higher in those subjects 
who demonstrated a reversibility on bronchodilators than those whose FEV1 
values were not reversible post bronchodilators. This association of  increased 
peripheral eosinophils with patients who had reversibility on bronchodilators 
was found to be statistically significant  suggesting a presence of 36.2%  
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Co morbid illnesses 
Diabetes and Systemic Hypertension 
More than one third of our patients had been diagnosed with diabetes or 
hypertension or both. In our study group 28 (30.8%) had diabetes and 32 
(35.2%) had systemic hypertension. In this group, 13 patients had both diabetes 
and hypertension. In the female COPD patients 9.8% gave history of ischemic 
heart diseases. 




Presence of Pulmonary Hypertension in our patients 
Presence and severity of pulmonary hypertension correlated with 
severity of airflow obstruction. ECG and Echocardiogram done and showed the 
following results 
Table 15 : Prevalence of Pulmonary Hypertension 
Pulmonary Hypertension  No. of patients % of patients 
Mild 5 5.4 
moderate 2 2.1 
With right heart failure 1 1 
 
Table 16: Association of Pulmonary hypertension with severity of airflow 
obstruction 
Co-morbid conditions 
Degree of airflow obstruction 














x2 = 8.844, df = 2, p 
= 0.008 
 
Presence and severity of depression in our patients 
Astonishingly only 3 patients had no symptoms based on PHQ9 
questionnaire indicating that 96.7% of patients had some forms of depression. 
Majority of the patients belong to the moderate symptoms of depression, 
almost 37 (40.7%).  21 (23.1%) patients had moderately severe symptoms of 
64 
 
depression .In our study group, 18 (19.1%) patients had mild symptoms of 
depression. Only 12 patients had very severe symptoms of depression. 
Fig 29: Distribution of patients by severity of depression 
 
CT phenotypes in our population 
In our group of 91 patients,HRCT could not be taken in 10 patients as 7 
of them were not willing to do it and 3 of them did not come back with the 
report.Phenotyping was done by experienced radiologists based on % oflow 
attenuation areas, bronchial wall thickening  and airtrapping.  Of the remaining 
81 patients, 41 (45.1%) had airway predominant phenotype, 15 (16.5%)   had 
emphysematous predominant phenotype and 25(27.5%) had mixed phenotype. 





Table 17: Distribution Of CT Phenotypes in our patients 
CT Phenotype Frequency ( n = 91 ) % of patients 
Airway  41 45.1 
Emphysematous 15 16.5 
Mixed 25 27.5 
 
Fig 30: Distribution in patients by CT phenotypes 
 
UNIVARIATE ANALYSIS TO FIND FACTORS ASSOCIATED WITH 
DEGREE OF AIRFLOW OBSTRUCTION:  
SOCIO DEMOGRAPHIC FACTORS & DEGREE OF AIRFLOW 
OBSTRUCTION: 
Among the socio demographic variables, age of the study subjects was 
found to have significant association (p=0.012) with degree of airflow 
obstruction. Other factors like education, occupation, socioeconomic status, 
type of housing, separate kitchen and nearness to busy road were not 
significantly associated with degree of airflow obstruction. These results are 
shown in the following Table . 
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Table  18 : Association of socio demographic factors with degree of 
airflow obstruction (n=91). 
Socio-demographic profile 
Degree of airflow obstruction 
Fisher’s 








41 - 50 22 (37.9) 5 (17.2) 0 (0) x
2 = 
14.091, df 
= 6, p = 
0.012 
51 - 60 23 (39.7) 10 (34.5) 1 (25.0) 
61 - 70 13 (22.4) 13 (44.8) 2 (50.0) 
>70 0 (0) 1 (3.4) 1 (25.0) 
Education Illiterate 39 (67.2) 15 (51.7) 3 (75.0) x
2 = 2.224, 
df = 2, p = 
0.382 








25 (43.1) 12 (41.4) 2 (50.0) 
x2 = 0.267, 








Upper middle 1 (1.7) 0 (0) 0 (0) 
x2 = 2.554, 
df = 6, p = 
1.000 
Lower middle 6 (10.3) 3 (10.3) 0 (0) 
Upper lower 47 (81.0) 24 (82.8) 4 (100) 
Lower 4 (6.9) 2 (6.9) 0 (0) 
Type of 
housing 
katcha 35 (60.3) 17 (58.6) 3 (75.0) x
2 = 0.387, 
df = 2, p = 
1.000 
non katcha 
23 (39.7) 12 (41.4) 1 (25.0) 
Separate 
kitchen 
present 18 (31.0) 8 (27.6) 1 (25.0) x
2 = 0.233, 
df = 2, p = 
0.919 
absent 
40 (69.0) 21 (72.4) 3 (75.0) 
Nearness to 
busy road  
present 24 (41.4) 13 (44.8) 3 (75.0) x
2 = 1.670, 
df = 2, p = 
0.424 
absent 




FACTORS AFFECTING THE SEVERITY OF THE DISEASE 
AGE  AND  SEVERITY OF AIRFLOW OBSTRUCTION: 
The mean age (in years) among study subjects with moderate, severe 
and very severe degree of obstruction was found to be 54.60, 59.48 and 65.25 
respectively. It was observed that as the age of the study subjects increased, the 
degree of airflow obstruction also increased. This difference in mean was found 
to be statistically significant (p=0.002) as depicted in Table   . 
Table 19  : Association of age with degree of airflow obstruction (n=91). 
Variable 
Degree of airflow obstruction 











F value p value 








Figure 31: Bar graph showing distribution of COPD severity across age 




CORRELATION OF CAT SCORE& DEGREE OF AIRFLOW 
OBSTRUCTION: 
When the severity of symptoms was assessed with COPD Assessment 
Test (CAT), it was observed to be significantly associated with the degree of 
airflow obstruction (p=0.000).  This can be studied in Table   . 
Table 20  : Association of CAT scoring of symptom severity with degree of 
airflow obstruction (n=91). 
CAT scoring of symptom 
severity 











low 2 (3.4) 0 (0) 0 (0) 
x2 = 
27.576, 
df = 6, p 
= 0.000 
medium 21 (36.2) 1 (3.4) 0 (0) 
high 29 (50.0) 17 (58.6) 0 (0) 
very high 6 (10.3) 11 (37.9) 4 (100.0) 
 




The median CAT score for symptom severity was found to be increasing 
as the degree of airflow obstruction increases. Difference in this median was 
observed to be statistically significant (p=0.000) as depicted in Table   . 
Table 21  : Association of CAT scoring of symptom severity with degree  
of airflow obstruction (n=91). 
 

















Figure 34: Scatter plot showing distribution CAT score and FEV1 
 
CORRELATION OF mMRC GRADING OF DYSPNEA AND 
SEVERITY OF AIRFLOW OBSTRUCTION 
Breathlessness of the study subjects was assessed by mMRC grading of 
dyspnea. Percentage of predicted FEV1 values were classified as low risk 
(<50%) and high risk (>50%) of airflow obstruction. There was a significant 
association (p=0.039) noted between mMMRC grading of dyspnea and the 




Table  22 : Association of mMRC grading of dyspnea with risk of  




Risk of airflow obstruction 
Fisher’s Exact test low risk 
n (%) 
high risk  
n (%) 
Grade – 0  1 (1.8) 0 (0) 
x2 = 8.796, df = 4,  
p = 0.039 
Grade – 1 5 (8.9) 0 (0) 
Grade – 2  22 (39.3) 9 (25.7) 
Grade – 3  27 (48.2) 22 (62.9) 
Grade – 4  1 (1.8) 4 (11.4) 
  




The median mMRC grade of dyspnea was observed to be higher in 
patients with high risk of airflow obstruction (3.0) when compared to patients 
with low risk of airflow obstruction (2.5). This difference in median was 
found to be statistically significant (p=0.005) as depicted in Table   . 
Table 23  : Association of mMRC grading of dyspnea with risk of  
airflow obstruction (n=91). 
 
NUTRITIONAL STATUS & DEGREE OF AIRFLOW OBSTRUCTION: 
Height and weight of the study subjects were measured and their 
nutritional status was assessed by calculating the body mass index (BMI). It 
was observed that subjects at higher risk of airflow obstruction had a 
significantly (p=0.020) lower BMI (21.45 kg/m2) as compared to subjects at 
lower risk of airflow obstruction (22.95 kg/m2). This observation is depicted in 
the Table    below. 
  
Variable 
Risk of airflow obstruction 







2.5 (1.0) 3.0 (1.0) 
p = 0.005 
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Table 24  : Association of BMI with risk of airflow obstruction (n=91). 
Nutritional 
status 
Risk of airflow obstruction 





t value p value 
 
Fig 36 : Scatterplot showing distribution of BMI and FEV1 
BIOMASS EXPOSURE & DEGREE OF AIRFLOW OBSTRUCTION: 
Biomass exposure index was calculated by multiplying the number of 
years of cooking with the number of hours spent in cooking on a whole day. 
Percentage of predicted FEV1 values were classified as low risk (<50%) and 
high risk (>50%) of airflow obstruction. From table   , it can be observed that 
as the number of years of exposure to biomass as well as the biomass exposure 
index increased, the risk of airflow obstruction also increased. This association 
of biomass exposure and risk of airflow obstruction was found to be 
statistically significant.  
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Table 25  : Association of biomass exposure with risk of  
airflow obstruction (n=91). 
Biomass exposure 






Mean (SE) t value 
p 
value 
Years of exposure to 
biomass  






48.66 (5.13) 68.60 (6.18) 2.484 0.015 
  
FIG : 37  Bar Graph showing association Biomass exposure and  





Table 26: Association of biomass exposure index with airflow limitation 
FIG 38: Scatter plot showing distribution of biomass exposure index and 
FEV1 
 
EXERCISE CAPACITY & DEGREE OF AIRFLOW OBSTRUCTION: 
The exercise capacity of the study subjects was calculated based on “6 
Minute Walk Distance” as recommended by American Thoracic Society. It was 
noted that the mean 6MWD observed value decreased as the severity of airflow 
obstruction increased. This association was statistically significant (p=0.000) as 









one way ANOVA 









Table 27: Association of exercise capacity with degree of  
airflow obstruction (n=91). 
Exercise 
capacity 






















FIG 39     Correlation between FEV1 and Observed 6MWD – Scatter plot 
 
Table 28: Association of 6MWD % with degree of  











Fisher’s Exact test 
0 - 50% 2 (3.4) 5 (17.2) 1 (25.0) 
x2 = 15.659, df = 4, p = 
0.001 
51 - 75% 
10 
(17.2) 
8 (27.6) 3 (75.0) 
76 - 100% 
46 
(79.3) 




Figure 40: Correlation between FEV1 and 6 MWD %- Scatter plot 
 
CT PHENOTYPE & SEVERITY OF AIRFLOW OBSTRUCTION: 
In the present study, it was observed that the CT phenotype of the study 
subjects was significantly associated with the risk of airflow obstruction. This 
is depicted in Table   . 
Table 29 :Association of CT phenotype with risk of  
airflow obstruction (n=91). 
CT phenotype 
Risk of airflow obstruction 
Pearson chi-square low risk 
n (%) 
high risk  
n (%) 
Nil 5 (8.9) 5 (14.3) 
x2 = 9.666, df = 4, p = 
0.046 
Airway 20 (35.7) 7 (20.0) 
Bronchiectasis 4 (7.1) 10 (28.6) 
Emphysematous 10 (17.9) 6 (17.1) 
Mixed 17 (30.4) 7 (20.0) 
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FIG 41: CT phenotypes across FEV ranges 
 
BIOMASS EXPOSURE & CT PHENOTYPE: 
The mean years of exposure to biomass was found to be 20.30, 31.93, 
17.00 and 19.67 respectively among those study subjects whose CT phenotype 
were found to be airway, bronchiectasis, emphysematous and mixed types. 
This difference in mean years of exposure to biomass among CT phenotype 
was found to be statistically significant (p=0.028), as shown in Table   . 

























































This cross sectional study was conducted on 91 female patients aged 
above 40 years presenting with symptoms suggestive of Chronic Obstructive 
Pulmonary Disease at the OPD of the department of thoracic medicine in Rajiv 
Gandhi Government General Hospital and Institute of Thoracic Medicine. This 
research was done in order to study the prevalence, socio-demographic, clinico-
radiological profile and also correlation of COPD assessment test (CAT) and 
degree of airflow obstruction infemales attending thoracic medicine OPD in 
this tertiary care centre. 
The mean FEV1 of our study population was 53.29% of predicted value. 
A similar value was observed by Raherison C et al in France (52.1%) [85] and 
Camp et al (57.7%) [34]The prevalence of degree of airflow obstruction in the 
present study was found to be 63.7%, 31.9% and 4.4% respectively for 
moderate, severe and very severe degrees. None of them were in the mild 
degree. Possible reasons for this would be the slowly progressing pathology of 
COPD that renders many asymptomatic for initial years, despite the disease. 
Another explanation could be lack of awareness by health care providers who 
may miss a spirometry in the initial stages of the disease and end up in “under-
diagnosis”.  
Majority (63.7%) of our study subjects were having moderate degree of 
airflow obstruction.  Similarly, more than half of the study population of Sumer 
C et al too was suffering from moderate degree of airflow obstruction as 
evident by their FEV1 values.[38] Frei et al observed the degree of airflow 
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obstruction as per GOLD stagingas II: 64.0%; III: 21.8% and IV: 14.2%. The 
mean FEV1 was 55.6% of the predicted value.[86] 
In our study group 36.1% had significant reversibility of more than 12% 
and 200ml in FEV1% predicted after bronchodilator. Dal Negro R W et al had 
a prevalence of 22% of ACOS in his study population and also found increased 
prevalence of bronchiectasis and ACOS  in female COPD patients when 
compared with their male counterparts.[45] In the study by DeMarco R et al 
and MenezesM et al had 15 – 25% prevalence of ACOS like DalNegro RW et 
al. [33,87]The mean eosinophil count of this population was higher than the 
non reversible population suggesting history of atopy. 80% also gave history of 
atopy and dust allergy . In this 43.3% of the bronchodilator reversible 
population also gave history of adulthood asthma. 
The mean age of the study subjects in the present study was 56.63 years 
with a standard deviation of 8.074 years. More than two third of our study 
subjects were between the age group of 40 to 60 years. This is similar to the 
observations made by Jain NK et al.[88] The mean age in their study was 
found to be 58.34 ± 9.99 years. In the present study, it was observed that as the 
age of the study subjects increased, the degree of airflow obstruction also 
increased significantly (p=0.002). This is in line with the observations made by 
Sharifi H et al among the residents of Tehran, where prevalence of COPD 
increased considerably in elderly individuals.[89] Subjects aged beyond 55 
years were two times more likely to suffer from COPD [aOR (95% CI) = 2.17 
(1.27‑ 3.71)] when compared to their younger counterparts. Hagstad S etal 
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noted in their study that age above 65 years was associated with COPD with an 
aOR of 8.29. [64] Lee SJ et al and Jordan RE et al too reported advanced age 
as a risk factor for COPD. [68,91] 
In the present study, the most common symptom reported was cough (in 
70 patients), followed by sputum production (67), breathlessness (60) and 
wheeze (26).  Jain NK et al also observed a similar finding in their study.[88]  
About 94.7% of their female patients reported cough as a presenting symptom, 
followed by expectoration (71.3%), fever (37.8%) and pedal edema (12.9%). A 
slightly contrary observation was noted by Sharifi H et al in Tehran, where 
dyspnea was the most common presenting symptom (21.6%), followed by 
wheezing (21.0%), sputum production (16.2%) and chronic cough (9.5%).[89] 
Percentage of study subjects with mMRC dyspnea grade of 0, 1, 2, 3 and 
4 in the present study were 0%, 5.4%,  35.1%,  53.8%  and 5.4%  respectively. 
The median mMRC grading of dyspnea in the present study was observed to be 
higher in patients with high risk of airflow obstruction as described by their 
FEV1 values. Ozalevli S et al in their study, showed that dyspnea scores of 
patients derived by mMRC grading were significantly linked to their FEV1 
values. Significant association between other dyspnea severity scales and 
spirometry values have been observed by other authors namely Hajiro T et al, 
Sahebjami H et al and Mahler DAet al.[91,92,93] In fact, Hajiro T et al 
demonstrated better correlations of dyspnea with derangement in the health 




In the present study, almost three-fourths of the study subjects were in 
the severe or very severe category of the COPD assessment test used to assess 
the severity of symptoms pertaining to COPD. Okutan O et al, in their study 
observed that out of 90 patients, 24 were in CAT 1, 33 in CAT II, 27 in CAT 
III and 6 were in CAT IV category. [94] 
CAT scoring was significantly associated (p=0.000) with the degree of 
airflow obstruction in the present study. This association of CAT score with the 
degree of airflow obstruction was also significantly observed by Sumer C et 
al.[38] In their study, a low CAT scoring was observed in mild and moderate 
COPD cases whereas a high CAT score was seen in severe and very severe 
cases (p=0.004). Hassan G et al and Mackay et al also observed that patients 
with severe COPD have significantly (p<0.032) higher CAT scores.[36,39] 
Ghobadi et al revealed a significant correlation (p<0.001) between GOLD 
classification of COPD and mean CAT scores. [36] 
In the present study, the median CAT score among subjects with 50 – 
80% predicted FEV1 was 21, those with 30 – 50% had median CAT score of 
29 and those whose predicted FEV1 was less than 30% had median CAT score 
of 31. A negative correlation was observed between CAT scores and predicted 
FEV1 values. These results are in line with those of Chai JJ et al[95] (r = -
0.567, p<0.01), Miyazaki et al[96] (r = -0.258, p< 0.001), Dal Negro RW et 
al[97](r = -0.21, p<0.001) as well as those of Mishra AR et al.[98] From the 
observations by all these authors, it can be affirmatively concluded that health 
impairment in COPD is associated with high CAT scores and lower values of 
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FEV1.CAT scoring thus provides a useful tool for screening for COPD 
patients, especially in settings where availability of spirometry is doubtful. 
However, the prognostic value of the COPD assessment test needs to be 
ascertained by a prospective follow-up study. 
In the present study, the average number of exacerbations among 
moderate, severe and very severe degree of obstruction was found to be 0.90, 
1.28 and 3.25 respectively. It was evident that as the degree of airflow 
obstruction increased, the number of exacerbations too increased.  Mackay AJ 
et al [39]observed that those with frequent exacerbations had a significantly 
(p=0.025) higher CAT score (19.5) when compared to those with less frequent 
exacerbations (16.8). During the exacerbations, it was also noted by the authors 
that the rise in CAT scores were significantly associated with a fall in FEV1 
(p=0.032). The authors concluded that CAT scores increase during 
exacerbations and hence reflect the severity of the underlying disease. Okutan 
O et al [94] also observed a similar correlation of exacerbations with CAT 
scoring in their study. 
Marco et al,[33] in their study on European population observed that 
respiratory infections in childhood and a family history of asthma were 
significant risk factors of COPD. An adjusted incidence rate ratio of 1.88 (1.02, 
3.46) and 1.95 (1.25, 3.04) were observed respectively for childhood 
respiratory infections and familial asthmatic history for the incidence of 
chronic obstructive pulmonary disorders. But in the present study, such a 
significant association could not be demonstrated. Possible explanations may 
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be due to differences in rates caused by genetic susceptibility or geographic 
variations. 
         In our study population out of the 35 who were homemakers, 28 
had exposure to biomass fuel at home thus exposing them for longer hours. In 
our study 17 were constructional workers, another 17 agricultural workers, 5 
were sweepers, 5 were cooks, 5 housemaids and 4 were flour handlers. These 
exposures were proven as significant risk factors for the development of COPD 
by John Dement et al[69]in his study on airways obstruction among 
construction workers, Ye M et al in his literature showed associations between 
chronic bronchitis and/or COPD and exposures to pesticides/herbicides and 
grain dusts,[ 70] Hamdy A et al showed significantly higher prevalence of 
chronic obstructive pulmonary disease in mill workers was work-related 
(40% vs. 0.0%; P < 0.0001) [71,72]]. Though none of the occupation showed 
significant correlation with severity of the disease may be due to the relatively 
smaller sample size of the present study or difference in the methodology when 
compared to those studies.  
In the present study, co morbid conditions such as diabetes, 
hypertension and psychiatric illness did not associate significantly with the 
airflow obstruction. About 9.8%  gave history of  ischemic heart disease . In 
COMCOLD study 20.6% had evidence of symptomatic heart disease.[86] 
Mackay AJ et al[39]in their study did not notice any significant difference 
between the mean CAT scores among the study subjects having co-morbid 
conditions such as ischemic heart diseases, cyanotic heart diseases, 
87 
 
hypertension, diabetes, chronic kidney disease, obstructive sleep apnea and 
obesity.  
Raherison C et al[85]in France observed among their women study 
subjects, the prevalence of co-morbid conditions such as arterial hypertension 
(32.9%) osteoporosis (19.6%), dyslipidemia (16.7%) and diabetes (6.5%). 
Except diabetes and hypertension, other co-morbidities were significantly 
differing between male and female COPD patients.  Lee et al[68]observed that 
bronchiectasis or a history of tuberculosis were strong risk factors for COPD. 
Frei et al[86]observed that among the co-morbid conditions, most commonly 
prevalent was hypertension (42.3%), and followed by arthritis (29.4%). 
Diabetes was found to have an impact on health status of COPD patients on 
univariate analysis. But its significance was lost when analyzed along with 
other co-morbidities in multivariate analysis.  
In the present study, it was noted that Body Mass Index of subjects at 
higher risk of airflow obstruction (21.45 kg/m2) was significantly less when 
compared to those at lower risk of obstruction (22.95 kg/m2). Being 
underweight was observed to be associated with a higher risk of COPD.Marco 
et al[33]observed that those with a BMI below 18.5 kg/m2 were thrice more 
likely to develop COPD [adjusted incidence rate ratio (95% CI) 3.55 (1.59 – 
7.93)] when compared to those with adequate nutritional status. Similar results 
were noted by Lee et al[68] also in their multivariate analysis [aOR (95% CI) 
3.1 (1.0 – 9.4), p = 0.045]. About 29.5% of the female study subjects of 
Raherison C et al[85]were having a BMI below 21.0 kg/m2 similar to our study 
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which had 34%  BMI below 21.0 kg/m2.Biomass exposed COPD patients had a 
higher BMI compared to tobacco smoke exposed COPD patients in studies 
done by both Ramirez Venegas et al and Camp et al.[102,34] 
Verhage et al[99]in their study in Netherlands observed that there was a 
significant correlation between fat free mass index and diffusion capacity. 
PothiratC et al[100] in their study noted that the fat free mass showed a 
significant positive correlation with the FEV1% values (r = 0.214, p = 0.019) 
and a significant negative correlation with CAT scores (r = -0.278, p = 0.002) 
and mMRC gradings (r = -0.315, p< 0.001). The authors also observed a 
correlation between body mass index and FEV1%, CAT scores and mMRC 
scores, but the relation was insignificant.  
As per World Health Organization reports, about 4.3 million humans die 
every year prematurely from illnesses attributable to indoor air pollution due to 
solid fuels. 22% of these premature deaths are due to COPD.[101] Women 
exposed to high levels of indoor air pollutants are twice at risk to counter 
COPD than women who use cleaner fuels. Hu G et al.[12] in their meta-
analysis, have found that exposure to biomass fuel was a significant risk factor 
for COPD and chronic bronchitis. A Lancet article estimates that about half of 
the COPD related deaths in under developed countries are due to biomass 
exposure and more than three – fourths of these deaths are in women. 
In the present study, 73 out of 91 females had a history of exposure to 
biomass fuel during cooking. The mean biomass exposure index was 56.33 
with a standard deviation of 38.71. Almost 60% of our study population were 
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having a higher biomass index of above 60, indicating a chronic exposure to 
this indoor air pollutant.  
Ina meta-analysis conducted by Guoping Hu et al, [12]the authors 
concluded that individuals exposed to biomass smoke were more than two 
times likely to develop COPD compared to those not exposed [OR (95% CI) 
2.4 (1.9 – 3.3)]. Exposure to biomass smoke was established as a risk factor for 
COPD both in men [OR (95% CI) 4.3 (1.9 – 10.1)] and women [OR (95% CI) 
2.7 (2.3 – 3.3)]; both in Asian [OR (95% CI) 2.3 (1.4 – 3.8)] and non Asian 
population [OR (95% CI) 2.6 (1.7 – 3.7)]; and also both in cigarette smokers 
[OR (95% CI) 4.4 (1.4 – 4.7)] as well as non smokers [OR (95% CI) 2.6 (2.1 – 
3.2)]. 
Kurmi OP et al [41] noted in their study that the prevalence of airflow 
obstruction was twice as common among users of solid fuels (8.1%) when 
compared to users of LPG (3.6%). The difference in airflow obstruction based 
on the type of fuel used was statistically significant (p = 0.001). The Odds ratio 
of airflow obstruction for females using solid fuels 2.38. The spirometry values 
were significantly reduced among the biomass users across all ages when 
compared to non users.  
Jain et al[88]noted that 89% of their female study subjects were 
exposed to biomass fuel smoke. Increased prevalence of airflow obstruction 
due to solid fuel exposure has been observed in COPD patients by various 
authors worldwide. It was also observed in the present study that as the number 
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of years of exposure to biomass as well as the biomass exposure index 
increased, the risk of airflow obstruction also increased significantly.  
Reasons for this observation include the higher vulnerability of Indian 
women to smoke from biomass and tobacco, or gender differences in health 
care seeking behavior, or ignorance by the health care provider resulting in a 
diagnostic delay due to knowledge gap about the usage of spirometry. Our 
findings are in accordance with those of Pérez-Padilla et al[16]and Ramírez-
Venegas et al.[102] In our study 68.1% of patients were in the normal BMI 
range. Raherison et al [85]had 29.5% were below BMI < 21kg /m2 similar to 
our study.  Similar to Mitra et al [42]we found a correlation between BMI and 
GOLD staging based on airflow limitation in our study . There was no 
correlation between fat free mass and disease severity in our study population 
probably as most of our patients had a normal BMI. 
In the present study, 40 of 91 study subjects gave a history of living at 
the proximity of a busy road. Schikowski T et al[22]in Germany observed a 
significantly decreased lung function test among women living within 100 
meters from a busy road and they were having an OR (95% CI) of 1.79 (1.06 – 
3.02) to develop COPD, when compared to those living farther away. Various 
studies have observed a decreased lung function and increased incidence of 
respiratory diseases due to proximity to busy roads .But a significant 
association was not demonstrated in the present study. This can be due to the 
relatively smaller sample size of the present study or difference in the 
methodology when compared to those studies.  
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Jordan RE et al[90]in their study in England observed that exposure to 
passive smoking was found to have an increased risk of COPD, with an aOR 
(95% CI) of 1.05 (0.93 – 1.18) for 1 to 19 hours and aOR (95% CI) of 1.18 
(1.01 – 1.39) for 20 or more hours of exposure a week.  
Hagstad S et al[64]observed that the prevalence of COPD increased 
significantly (p = 0.003) as the exposure to environmental tobacco smoke 
(ETS) increased: prevalence was 4.2% in no ETS, 8.0% in ETS ever at home 
[OR (95% CI) 1.98 (1.2 – 3.2)], 8.3% in ETS at previous work [2.06 (95% CI) 
1.3 – 3.3] and almost 14.7% for ETS both at home and work (previous as well 
as current) [OR (95% CI) 3.94 (1.4 – 11.0)].  
Venegas AR et al[102]observed that a lower mean rate of FEV1 decline 
in the biomass exposed COPD patients than for the tobacco exposed COPD 
patients (23 vs. 42). About 11% of the tobacco smoke – COPD group were 
rapid decliners whereas only one patient was found to be a rapid decliner in the 
biomass exposed group.  The authors concluded that rapid rate of FEV1 decline 
was a feature more of tobacco smoke exposure than of biomass fuel exposure 
(p = 0.01).  
Only 3 of 91 study subjects in the present study gave a history of using 
smoking tobacco, of which one was diagnosed to have lung cancer. On the 
other hand, it was observed that 40 (44%) of the study subjects had an exposure 
to second hand smoke. Second hand smoke exposure did not show a significant 
association with degree of airway obstruction in the present study. In a study 
done in Korea by Lee et al,[68] second hand smoke was significantly 
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associated with COPD risk in univariate analysis, but failed to emerge as an 
independent predictor in multivariate analysis. Contrarily, Wu CF et 
al[103]observed exposure to second hand smoke as a risk factor for COPD. 
Reasons for this may be attributed to the differences in the methodology of 
these studies. American Thoracic Society, in their official statement, concludes 
that review of the present literature presents a suggestive evidence of 
association between second hand smoke exposure and COPD development. 
[104] 
In our study population 45.1% had airway phenotype,  27.5%  had 
mixed phenotypes and 16.5% had emphysematous phenotypes. Out of the 73 
who had exposure to the biomass 6 of them did not take HRCT. In the biomass 
exposed individual who had taken CT chest 54.5% had airway phenotype, 
29.8% had mixed phenotype and 16.7% had emphysematous phenotype in CT . 
This is consistent with study by Camp et al in Mexican women.[34 ] The 
airway phenotype was common in biomass smoke exposed women as biomass 
fuel is inhaled in consistent tidal respiration and women’s respiration is mostly 
thoracoabdominal. They do not inhale deeply and the particles settle in airways 
and do not go deeper and result in airway predominant phenotype as opposed to 
men who inhale an extra volume of air when smoking leading to 






 This is a cross sectional study on 91 female patients aged above 
40 years presenting to OPD with symptoms suggestive of COPD.  
 The mean FEV1 of the study population was 53.29% of 
predicted. 
 Prevalence of airflow obstruction as defined by GOLD guidelines 
was as follows: 0% in mild degree (FEV1 > 80% of predicted), 
63.7% moderate (FEV1 50% to 80% of predicted), 31.9% severe 
(FEV1 30% to 50% of predicted) and 4.4% were having very 
severe (FEV1 < 30% of predicted) degree of airflow obstruction. 
 Majority (63.7%) were having moderate degree of airflow 
obstruction. 
 Most of the study subjects (72.1%) were aged below 60 years. 
 The most commonly reported symptom was cough (70 patients). 
 Dyspnea grade 3 (53.8%) followed by grade 2 (35.1%) was 
reported by most of the study subjects, as per mMRC grading of 
dyspnea.  
 About half of the study subjects (50.5%) were categorized high 
as per CAT scoring of COPD symptom severity.  
 Majority (82.4%) of the study subjects were belonging to upper 
lower scale of socio economic status as per 
modifiedKuppuswamy’s classification.  
 More than half (63%) of the study subjects were illiterates. 
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 About 53 study subjects had one or more exacerbations. 
 The mean fat free mass of the study population was 31.87. 
 About 9.9% of our study subjects were undernourished as per 
Quetlet index, while 68.1% of them were normal. 
 44% of the study subjects reported living in proximity to a busy 
road. 
 About 15.4% of study subjects gave history of asthma more than 
10 years. 
 Prevalence of diabetes among the study population was found to 
be 30.8%  
 Prevalence of systemic hypertension was found to be 35.2%  
 About 40.7% of the study subjects had moderate depression as 
per PHQ9 questionnaire. 
 41 study subjects had airway phenotype on CT examination, 
whereas 25 had mixed phenotype and 15 had emphysematous 
phenotype.  
 30 study subjects had significant reversibility of airflow 
obstruction.  
 Only 3 study subjects revealed a history of tobacco smoking and 
all were of moderate smoking index (100 – 300). 
 Exposure to second hand tobacco smoke was found in 44%.  
 59.3% of the study subjects had a biomass exposure index greater 
than 60.  
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 Variables significantly associated with degree of airflow 
obstruction in COPD patients include elderly age, mMRC grade 
of dyspnea, CAT scoring of symptom severity, exacerbations, 
biomass exposure index, number of years of biomass exposure, 
pulmonary hypertension, exercise capacity by 6MWD, body 
















1. In this study the prevalence of airflow obstruction  in female 
COPD ( as defined by GOLD guidelines) as follows: 0%  mild 
degree, 63.7% moderate, 31.9% severe and 4.4% very severe 
degree of airflow obstruction. 
2. About 3.2% of the female COPD patients were smokers. 
3. Two third of the study population had exposure to solid biomass 
fuel at home with biomass exposure index above 60 as the most 
common risk factor. 
4. One third of the female COPD patients were home makers who 
were at risk of increased exposure to biomass at home. 
5. Two third of the study population had exposure to occupational 
dusts and chemicals as they were doing occupations like 
construction work (18.6%), agricultural work (18.6%), sweeping 
(5.4%), cooking (5.4%) and handling flour (5.4%).  
6. Majority of the study subjects were  middle aged and belonged to 
Upper Lower scale of Socio-economic status 
7. Most of the study subjects had cough as the commonly reported 
symptom, with a high CAT score of symptom severity and 
mMRC grade 3 dyspnea. 
8. Only one tenth of the female COPD patients were  underweight  
based on Quetlet index. 
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9. About half of the female COPD patients had moderate degree of 
depression. 
10. One third of the patients hadsignificant reversibility after a 
bronchodilator with increased peripheral eosinophil count 
probably suggesting an asthma overlap. 
11. The most common CT phenotype was Airway Predominant 
Phenotype followed by Mixed Phenotype and Emphysematous 
Predominant Phenotype being the least common type. 
12. Among the socio demographic variables age of the study 
population was found to have a statistically significant 
association with the degree of airflow obstruction. 
13. Of the clinico-radiological parameters, mMRC grade of dyspnea, 
CAT scoring of symptom severity, number of exacerbations, 
exercise capacity by 6MWD, body mass index and CT phenotype 
were found to have a statistically significant association with the 
degree of airflow obstruction. 
14. Both number of years of biomass exposure and biomass exposure 
year hours (biomass exposure index) both had a significant 
association with degree of airflow obstruction with number of 
years of exposure being more significant than biomass exposure 
year hours (Biomass exposure index).  
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15. This study stresses the need for increased awareness in the 
society especially in the women population in avoiding solid 
biomass fuel at home and changing to alternate fuels for cooking.  
16. Spirometry should be included as primary screening tool in 
women with history of biomass exposure and respiratory 




















1. No controls were included in the study. 
2. Most of the risk factors obtained were self reported answers for 
questionnaires which were recall based  
3. The risk of exposure was not quantitatively measured. 
4. Clinical parameters such as arterial blood gas analysis, diffusion 
capacity of lung of carbon monoxide and sputum eosinophil percentage 
could not be assessed. 
5. Institution based study hence does not reflect the true profile of COPD 





1. There is a paradigm shift of fuel used for cooking from biomass to LPG 
in both rural and urban population due to various government schemes 
like Pradhan Mantri UjjwalaYojana scheme. Intensified implementation 
of these schemes by the government can cause a reduction in biomass 
exposure thereby reducing the prevalence of biomass induced COPD in 
the female population. 
2. Stringent measures like protective gears or mechanisation of certain 
processes can be strictly enforced in occupations like construction work, 
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PATIENT INFORMATION SHEET 
 
TITLE OF THE STUDY: “To study the prevalence, sociodemographic, clinico-
radiological profile and also correlation of COPD assessment test (CAT) and 
degree of airflow obstruction in Chronic Obstructive Pulmonary Disease in 
females” 
We are conducting a study  among patients attending thoracic medicine department in 
Rajiv Gandhi Government General Hospital and Institute of Thoracic Medicine, 
Chennai. 
The purpose of this study is to analysethe prevalence, sociodemographic, clinico-
radiological profile and also correlation of COPD assessment test ( CAT) and 
degree of airflow obstruction in Chronic Obstructive Pulmonary Disease in 
females” 
We are selecting female patients aged 40 yrs and above presenting with symptoms of 
cough, sputum, breathlessness, wheeze for more than 2 weeks withspirometry post 
bronchodilator FEV1/FVC< 0.70.Patients will undergo basic blood investigations, 
chest X-ray / CT chest(if needed), DLCO to arrive at a diagnosis and subsequently 
treat the patient. 
The privacy of the patients in the research will be maintained throughout the study. In 
theevent of any publication or presentation resulting from the research, no personally 
identifiable information willbe shared. 
Taking part in this study is voluntary. You are free to decide whether to participate in 
this studyor to withdraw at any time; your decision will not result in any loss of 
benefits to which you areotherwise entitled. 
The results of the special study may be intimated to you at the end of the study period 
















PATIENT CONSENT FORM 
Study detail:  “To study the prevalence, sociodemographic, clinico-radiological    
profile and also correlation of COPD assessment test ( CAT) and degree of airflow 
obstruction in Chronic Obstructive Pulmonary Disease in females attending tertiary 
care  





Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and doubts 
have been answered to my complete satisfaction.     
      
b) I understand that my participation in the study is voluntary and that I am free 
to withdraw at any time without giving reason, without my legal rights being 
affected 
 .  
c) I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities will not 
need my permission to look at my health records, both in respect of current 
study and any further research that may be conducted in relation to it, even if I 
withdraw from the study I agree to this access. However, I understand thatmy 
identity will not be revealed in any information released to third parties or 
published, unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study.      
   
d) I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms.   
         
e) I hereby consent to participate in this study.    
  
f) I hereby give permission to undergo detailed clinical examination, 
Radiographs ,blood investigations and surgical procedure as required.  
      
Signature/thumb impression    Signature of Investigator 












IP /OP number : 
Sociodemographic history : 
Presenting complaints : 
History of presenting illness : 
Past history : 
Personal history : 
Occupational history : 
CAT questionnaire scoring : 
Modified Medical Council grades(mMRC)  : 
Patient health questionnaire – 9 score :  
Nutritional status : Body Mass Index  : 
 Fat free mass  : 
General examination : 
Systemic examination : 
Blood investigations : 
Radiological findings : 
Chest xray  : 
CT-Chest : 
Sputum investigations : 
Spirometric analysis : 
DLCO :  
Final diagnosis 
 
 
 
 
 
 
 
 
 
 
 
 
